Spago Nanomedical AB Cash Flow-to-Debt Ratio
Spago Nanomedical AB cash flow-to-debt ratio. Spago Nanomedical AB (SPAGO) has a Cash Flow-to-Debt Ratio of -1.04x as of December 2025, meaning its operating cash flow of Skr-6.19 Million could theoretically repay -1% of its total liabilities (Skr5.94 Million) in one year. See SPAGO FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Spago Nanomedical AB (2011–2025)
Cash flow-to-debt ratio of Spago Nanomedical AB from 2011 to 2025. Historical debt coverage capacity for Spago Nanomedical AB across 15 annual periods. Check SPAGO capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Spago Nanomedical AB Cash Flow-to-Debt Ratio by Year (2011–2025)
Spago Nanomedical AB cash flow-to-debt ratio by year from 2011 to 2025. Year-by-year debt coverage analysis for Spago Nanomedical AB. For the full cash flow conversion analysis, see Spago Nanomedical AB cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -4.77x | Skr-28.30 Million | Skr5.94 Million | ▲ +12.7% |
| 2024 | -5.46x | Skr-34.67 Million | Skr6.35 Million | ▼ -41.9% |
| 2023 | -3.85x | Skr-44.91 Million | Skr11.67 Million | ▲ +11.3% |
| 2022 | -4.34x | Skr-38.19 Million | Skr8.80 Million | ▲ +16.9% |
| 2021 | -5.22x | Skr-35.57 Million | Skr6.81 Million | ▲ +12.5% |
| 2020 | -5.97x | Skr-18.77 Million | Skr3.15 Million | ▲ +18.5% |
| 2019 | -7.32x | Skr-21.29 Million | Skr2.91 Million | ▼ -185.3% |
| 2018 | -2.57x | Skr-10.51 Million | Skr4.10 Million | ▼ -26.5% |
| 2017 | -2.03x | Skr-7.73 Million | Skr3.81 Million | ▼ -112.0% |
| 2016 | -0.96x | Skr-7.86 Million | Skr8.22 Million | ▼ -67.0% |
| 2015 | -0.57x | Skr-5.34 Million | Skr9.33 Million | ▼ -88.0% |
| 2014 | -0.30x | Skr-5.95 Million | Skr19.53 Million | ▲ +22.4% |
| 2013 | -0.39x | Skr-7.74 Million | Skr19.69 Million | ▼ -642.6% |
| 2012 | -0.05x | Skr-601.00K | Skr11.36 Million | ▼ -138.2% |
| 2011 | -0.02x | Skr-276.00K | Skr12.42 Million | — |